Ribhi Shawar of FDA
joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss
'FDA regulation of clinical microbiology and AST diagnostic devices'
.
In this presentation, learn about
some examples of challenges in data presentation/analysis as well as scientific and regulatory process understanding.
Download the presentation to understand more about:
-
Progress in microbial diagnostics, including AMR
-
Highlights of efforts and initiatives
-
Efforts on coordinated development between CDRH and CDER
-
The joint interagency FDA/CDC: Antimicrobial-Resistant Isolates Bank
-
Curated Genomic Sequence Debates
-
Resources
..and
much
more!
Get your copy here!
To find out more about
progress in AMR diagnostics and the efforts of the FDA against AMR
, attend
World Anti-Microbial Resistance Congress USA 2016
held
September 8-9
in
Washington, DC
.